A new generation of potentially safer and more cost-effective therapeutics against West Nile virus, and other pathogens
An international research group led by Arizona State University professor Qiang “Shawn” Chen has developed a new generation of potentially safer and more cost-effective therapeutics against West Nile virus, and other pathogens.
The therapeutics, known as monoclonal antibodies (MAbs) and their derivatives, were shown to neutralize and protect mice against a lethal dose challenge of West Nile virus—even as late as 4 days after the initial infection.
“The overarching goal of our research is to create an innovative, yet sustainable and accessible, low cost solution to combat the global threat of West Nile virus,” said Chen, a researcher at Arizona State University’s Biodesign Institute and professor in the Department of TEIM.
West Nile virus is spread by infected mosquitoes, and targets the central nervous system. It can be a serious, life-altering and even fatal disease and currently, there is no cure or drug treatment against West Nile virus, which has been widely spread across the U.S., Canada, Latin America and the Caribbean.
“The goal of this latest research was twofold,” said Chen. “First, we wanted to show proof-of-concept, demonstrating that tobacco plants can be used to manufacture large and complex MAb-based therapeutics. Secondly, we’ve wanted to improve the delivery of the therapeutic into the brain to combat West Nile virus at the place where it does the greatest harm.”
The study appears in the March 27 online edition of PLOS ONE. Along with Chen, the research team included Junyun He, Huafang “Lily” Lai, Michael Engle, Sergey Gorlatov, Clemens Gruber, Herta Steinkellner and long-time Washington University collaborator Michael S. Diamond.
Chen’s group has been a pioneer in producing MAbs as therapeutic candidates in plants, including tobacco and lettuce plants. A couple of years ago, his team demonstrated that their first candidate, pHu-E16, could neutralize West Nile infection and protect mice from exposure. MAbs target proteins found on the surface of West Nile virus.
However, this antibody was not able to accumulate at high levels in the brain.
One approach to tackle this challenge is to program into the therapeutic antibodies the capability of binding to receptors that can help the MAbs to cross into the brain. Chen wanted to use this strategy to produce a more effective way to combat West Nile virus.
In the new study, they improved upon their pHu-E16 design, making half a dozen new variants that could, for the first time, lead to the development of MAbs that effectively target the brain and neutralize West Nile virus.
Mice were infected with a lethal dose of West Nile virus, and increasing amounts of a MAb therapeutic were delivered as a single dose the same day of infection. In another experiment, Chen’s team tested whether the therapeutic, called Tetra pHu-E16, could be effective after infection. In this case, the therapeutic was administered 4 days after West Nile virus infection, when the virus has already spread to the brain. In each case, they protected up to 90 percent of the mice from lethal infection.
This is the first instance of such an effect and makes possible neutralizing West Nile virus even after infection by a tetravalent MAb. The tetravalent MAbs design will offer the researchers greater flexibility toward selection of disease, tissue and antigen targets.
For Chen, this also gives promise to his team developing a plant-based system to dramatically reduce the costs of commercial manufacturing of MAbs.
“This study is a major step forward for plant-based MAbs, and also demonstrates for the first time the capacity of plants to express and assemble large, complex and functional tetravalent MAb complexes,” said Chen.
MAbs are a hot and highly competitive research field, having been shown to effectively target cancer, autoimmune and inflammatory diseases. Now a $60 billion market for the biotechnology and pharmaceutical sectors, growth of the market has been hampered by high development costs of producing these in animal cell systems, which when factoring in a long period for manufacturing, R&D and clinical trials, may reach around $1 billion per each therapeutic candidate.
Therapeutic MAbs are typically made in animal host cells and assembled into Y-shaped complexes. Until now, tetravalent MAbs had never been made in a plant system before. To make the potential therapeutics, the group is able to use young tobacco plants and a protein expression system to make and harvest the proteins in the leaves.
For the study, MAbs were rapidly produced in tobacco plants in as little as ten days, giving promise to change the image of scourged product that causes lung cancer into a manufacturing system for societal benefits against infectious diseases.
“It is our hope that these results may usher in new age of cost-effective, MAbs therapeutics against WNV and other neurological diseases,” said Chen. “Our next step is to move this forward with the development of bifunctional MAbs that can target to the brain with the ultimate goal of entering human clinical trials.”
The Latest on: West Nile virus
[google_news title=”” keyword=”West Nile virus” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: West Nile virus
- West Nile virus detected in dead bird in Menlo Park, Vector Control District urges residents to dump standing wateron May 17, 2024 at 11:58 am
West Nile virus has been detected in a dead bird in Menlo Park, according to a May 15 press release from the The District is encouraging residents to dump all standing water in their yards in order to ...
- Morgan County reports one of first West Nile virus batcheson May 17, 2024 at 11:48 am
West Nile virus found in Illinois mosquito batch in Morgan County, and earlier than usual; residents are urged to take precautions.
- First West Nile-positive mosquitoes found in Illinoison May 17, 2024 at 9:45 am
ILLINOIS (WCIA) — West Nile Virus is officially confirmed to be in the State of Illinois for 2024. The Illinois Department of Public Health reported that two mosquito batches in the state tested ...
- Illinois Department of Public Health reports first 2 mosquito batches of 2024 to test positive for West Nile Viruson May 17, 2024 at 9:42 am
Two batches of mosquitoes in Illinois have tested positive for West Nile Virus for the first time this year, the Illinois Department of Health announced on Friday. The Northwest Mosquito Abatement ...
- IDPH Reports First 2 Mosquito Batches to Test Positive in 2024 for West Nile Virus in Cook & Morgan Countieson May 17, 2024 at 8:50 am
CHICAGO The Illinois Department of Public Health (IDPH) announced today that it has confirmed the first two batches of mosquitoes to test positive in 202 ...
- Mosquito with West Nile virus found in Hoffman Estateson May 17, 2024 at 8:31 am
A sample of mosquitoes in Hoffman Estates has tested positive for West Nile virus, the Illinois Department of Public Health announced. The specimen in Hoffman Estates was collected May 14 by the ...
- First West Nile virus mosquito batches found in Illinois for 2024on May 17, 2024 at 3:46 am
The Illinois Department of Public Health (IDPH) announced that it has confirmed the first two batches of mosquitoes to test positive in 2024 for West Nile virus ...
- West Nile virus found in mosquitoes after recent rainfall in San Antonioon May 16, 2024 at 11:03 pm
Following recent rainfall, city health officials have confirmed a mosquito pool testing positive for West Nile Virus on the southwest side.The in ...
- Mosquito pool tests positive for West Nile virus in San Antonioon May 16, 2024 at 8:47 pm
SAN ANTONIO – A mosquito pool tested positive this week for West Nile virus in San Antonio, the first of the year. According to the Metro Health Department, the infected pool trap was collected on the ...
- San Antonio's first positive West Nile Virus test of 2024 reportedon May 16, 2024 at 8:01 pm
The City of San Antonio announced its first positive test of 2024 for West Nile Virus. It was found on the city's Southwest Side near Loop 410.
via Bing News